FibroBiologics, Inc. Common Stock
$0.61
(as of Jul 8, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for FibroBiologics, Inc. Common Stock
Stock Price
$0.61
Ticker Symbol
FBLG
Exchange
NASDAQ
Industry Information for FibroBiologics, Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Company Description for FibroBiologics, Inc. Common Stock
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.
Fundamentals for FibroBiologics, Inc. Common Stock
Market Capitalization
$24,015,736
EBITDA
$-14,643,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-0.21
Earnings per Share Estimate Next Year
Profit Margin
Shares Outstanding
39,241,400
Percent Owned by Insiders
21.42%
Percent Owned by Institutions
16.86%
52-Week High
52-Week Low
Technical Indicators for FibroBiologics, Inc. Common Stock
Analyst Ratings for FibroBiologics, Inc. Common Stock
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
News About FibroBiologics, Inc. Common Stock
Jul 7, 2025, 4:35 PM EST
HOUSTON, July 07, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. See more.
Jun 16, 2025, 4:48 PM EST
HOUSTON, June 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. See more.
Jun 16, 2025, 4:35 PM EST
HOUSTON, June 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. See more.
Jun 16, 2025, 9:50 AM EST
HOUSTON, June 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. See more.